Europe Microbiome Therapeutics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Microbiome Therapeutics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Microbiome Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Microbiome Therapeutics Market Regional Analysis

6.2 Europe Microbiome Therapeutics Market Revenue 2020-2030 (US$ Million)

6.3 Europe Microbiome Therapeutics Market Forecast Analysis

7. Europe Microbiome Therapeutics Market Analysis – by Type

7.1 Therapeutics and Procedure

7.1.1 Overview
7.1.2 Therapeutics and Procedure: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Microbiome Therapeutics Market Analysis – by Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview
8.1.2 Metabolic Disorder and Obesity: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 C. Difficile Infection

8.2.1 Overview
8.2.2 C. Difficile Infection: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Inflammatory Bowel Disease

8.3.1 Overview
8.3.2 Inflammatory Bowel Disease: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Microbiome Therapeutics Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Ambulatory Surgical Centers

9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Homecare

9.3.1 Overview
9.3.2 Homecare: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Microbiome Therapeutics Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Microbiome Therapeutics Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 Europe Microbiome Therapeutics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 UK: Europe Microbiome Therapeutics Market Breakdown, by Type
10.2.1.1.2 UK: Europe Microbiome Therapeutics Market Breakdown, by Application
10.2.1.1.3 UK: Europe Microbiome Therapeutics Market Breakdown, by End User

10.2.1.2 Germany: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown, by Type
10.2.1.2.2 Germany: Europe Microbiome Therapeutics Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Microbiome Therapeutics Market Breakdown, by End User

10.2.1.3 France: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 France: Europe Microbiome Therapeutics Market Breakdown, by Type
10.2.1.3.2 France: Europe Microbiome Therapeutics Market Breakdown, by Application
10.2.1.3.3 France: Europe Microbiome Therapeutics Market Breakdown, by End User

10.2.1.4 Russia: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Russia: Europe Microbiome Therapeutics Market Breakdown, by Type
10.2.1.4.2 Russia: Europe Microbiome Therapeutics Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Microbiome Therapeutics Market Breakdown, by End User

10.2.1.5 Italy: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.5.1 Italy: Europe Microbiome Therapeutics Market Breakdown, by Type
10.2.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by Type
10.2.1.6.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Caelus Health BV

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Enterome SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Ferring Holdings SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Vedanta Biosciences Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 YSOPIA Bioscience SA

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Microbiome Therapeutics Market

Analysis - by Type (Therapeutics and Procedure), Application (Metabolic Disorder and Obesity, C. Difficile Infection, Inflammatory Bowel Disease, and Others), and End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, and Others)